Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Myelogenous Leukemia (CML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02543749
What this trial is testing

DC Vaccination in CML

Who this might be right for
Myeloid Leukemia, Chronic
Charite University, Berlin, Germany 1
Testing effectiveness (Phase 2)Study completedNCT00267085
What this trial is testing

Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease

Who this might be right for
Chronic Myeloid LeukemiaMinimal Residual Disease
M.D. Anderson Cancer Center 11
Early research (Phase 1)Study completedNCT00420043
What this trial is testing

Effect of Food on Bioavailability of Modified Release Formulations of Imatinib

Who this might be right for
Healthy
Novartis 32
Large-scale testing (Phase 3)Temporarily pausedNCT01755325
What this trial is testing

Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

Who this might be right for
Chronic Myelogenous Leukemia
Junmin Li 680
Early research (Phase 1)Ended earlyNCT01751425
What this trial is testing

Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors

Who this might be right for
Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionMinimal Residual Disease+1 more
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT01207440
What this trial is testing

Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Chronic Myeloid LeukemiaPh+ Acute Lymphoblastic Leukemia
Ariad Pharmaceuticals 449
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191
What this trial is testing

Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Ended earlyNCT00644878
What this trial is testing

Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib

Who this might be right for
Chronic Myelogenous Leukemia - Chronic Phase
Novartis Pharmaceuticals 18
Early research (Phase 1)Study completedNCT00027144
What this trial is testing

Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase

Who this might be right for
Leukemia,Myeloid, ChronicLeukemia,Myeloid,Philadelphia-Positive
University of Connecticut 10
Testing effectiveness (Phase 2)Ended earlyNCT00415909
What this trial is testing

TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients

Who this might be right for
Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00375219
What this trial is testing

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT00171249
What this trial is testing

An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia

Who this might be right for
Philadelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Novartis Pharmaceuticals 293
Early research (Phase 1)Study completedNCT02081378
What this trial is testing

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

Who this might be right for
Chronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 326
Testing effectiveness (Phase 2)Study completedNCT00171158
What this trial is testing

An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis

Who this might be right for
Philadelphia Chromosome Positive CML
Novartis Pharmaceuticals 260
Testing effectiveness (Phase 2)UnknownNCT02268370
What this trial is testing

Treatment-free Remission Accomplished With Dasatinib in Patients With CML

Who this might be right for
Chronic Myeloid Leukemia
University Health Network, Toronto 131
Testing effectiveness (Phase 2)Study completedNCT01593254
What this trial is testing

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 262
Testing effectiveness (Phase 2)Active Not RecruitingNCT04761770
What this trial is testing

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Who this might be right for
Myelodysplastic SyndromeMyeloproliferative NeoplasmsChronic Myelomonocytic Leukemia+2 more
Memorial Sloan Kettering Cancer Center 33
Early research (Phase 1)Study completedNCT00047502
What this trial is testing

Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Large-scale testing (Phase 3)Study completedNCT00450450
What this trial is testing

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+7 more
Children's Oncology Group 27
Next Page